| David S Caldwell, MD | |
|
Duke University Medical Ctr, Durham, NC 27710-0001 | |
| (919) 684-8111 | |
| Not Available |
| Full Name | David S Caldwell |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 53 Years |
| Location | Duke University Medical Ctr, Durham, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982787123 | NPI | - | NPPES |
| 8920725 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 17318 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Duke University Hospital | Durham, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duke Health Integrated Practice Inc | 8325412737 | 2551 |
News Archive
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that AstraZeneca has informed the company that it plans to progress the development of Targacept's product candidate AZD1446 as a treatment for Alzheimer's disease.
A team of researchers used several assays, atomic force microscopy, and simulations to determine that the N501Y mutation in the virus's receptor-binding domain (RBD) increased the interaction of the virus with the angiotensin-converting enzyme 2 (ACE2) receptor.
The Royal College of Occupational therapists has launched a new guide, ‘Adaptations without delay' which will help speed up the process of delivering adaptations to people's homes.
Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of antibiotics.
A virtual reality tour of the operating room prior to anesthesia helped reduce preoperative anxiety in children scheduled to undergo surgery who took part in a clinical trial published in the BJS.
› Verified 6 days ago
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that AstraZeneca has informed the company that it plans to progress the development of Targacept's product candidate AZD1446 as a treatment for Alzheimer's disease.
A team of researchers used several assays, atomic force microscopy, and simulations to determine that the N501Y mutation in the virus's receptor-binding domain (RBD) increased the interaction of the virus with the angiotensin-converting enzyme 2 (ACE2) receptor.
The Royal College of Occupational therapists has launched a new guide, ‘Adaptations without delay' which will help speed up the process of delivering adaptations to people's homes.
Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of antibiotics.
A virtual reality tour of the operating room prior to anesthesia helped reduce preoperative anxiety in children scheduled to undergo surgery who took part in a clinical trial published in the BJS.
› Verified 6 days ago
| Entity Name | Duke Health Integrated Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that AstraZeneca has informed the company that it plans to progress the development of Targacept's product candidate AZD1446 as a treatment for Alzheimer's disease.
A team of researchers used several assays, atomic force microscopy, and simulations to determine that the N501Y mutation in the virus's receptor-binding domain (RBD) increased the interaction of the virus with the angiotensin-converting enzyme 2 (ACE2) receptor.
The Royal College of Occupational therapists has launched a new guide, ‘Adaptations without delay' which will help speed up the process of delivering adaptations to people's homes.
Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of antibiotics.
A virtual reality tour of the operating room prior to anesthesia helped reduce preoperative anxiety in children scheduled to undergo surgery who took part in a clinical trial published in the BJS.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David S Caldwell, MD Duke University Medical Ctr, Dumc 2978, Durham, NC 27710-0001 Ph: () - | David S Caldwell, MD Duke University Medical Ctr, Durham, NC 27710-0001 Ph: (919) 684-8111 |
News Archive
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that AstraZeneca has informed the company that it plans to progress the development of Targacept's product candidate AZD1446 as a treatment for Alzheimer's disease.
A team of researchers used several assays, atomic force microscopy, and simulations to determine that the N501Y mutation in the virus's receptor-binding domain (RBD) increased the interaction of the virus with the angiotensin-converting enzyme 2 (ACE2) receptor.
The Royal College of Occupational therapists has launched a new guide, ‘Adaptations without delay' which will help speed up the process of delivering adaptations to people's homes.
Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of antibiotics.
A virtual reality tour of the operating room prior to anesthesia helped reduce preoperative anxiety in children scheduled to undergo surgery who took part in a clinical trial published in the BJS.
› Verified 6 days ago
Dr. Stephen John Greene, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2301 Erwin Rd # Dumc3845, Durham, NC 27705 Phone: 919-684-8111 | |
Dr. Jacob Paul Feigal, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: Duke University Hospital Gme, Box 3951, Durham, NC 27710 Phone: 919-684-8111 | |
Dr. David Keith Bright, MD, PHARM D Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4205 Ben Franklin Blvd, Durham, NC 27704 Phone: 919-477-6900 Fax: 919-477-5081 | |
Yuri Anthony Fesko, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 4101 N Roxboro St, Durham, NC 27704 Phone: 919-684-8111 | |
Mary E Klotman, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 40 Duke Medicine Cir, Durham, NC 27710 Phone: 919-684-8111 | |
Jonathan Paul Piccini Sr., M.D., M.H.S. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 40 Duke Medicine Cir, Durham, NC 27710 Phone: 919-684-8111 | |
Dr. Deborah Anne Fisher, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 508 Fulton St, Durham, NC 27705 Phone: 919-286-6945 |